Camex Limited (BOM:524440)
India flag India · Delayed Price · Currency is INR
40.77
+1.71 (4.38%)
At close: Jul 30, 2025

Theseus Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jul '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
398352397240265203
Upgrade
Market Cap Growth
-11.24%-11.24%65.45%-9.62%30.65%95.87%
Upgrade
Enterprise Value
387431440283306226
Upgrade
Last Close Price
39.0134.5138.8823.5026.0019.90
Upgrade
PE Ratio
21.0318.6011.46-8.4314.95
Upgrade
PS Ratio
0.300.260.280.160.150.14
Upgrade
PB Ratio
0.930.820.97-0.670.60
Upgrade
P/TBV Ratio
0.930.820.97-0.710.60
Upgrade
P/FCF Ratio
89.9479.568.46-41.07-
Upgrade
P/OCF Ratio
6.295.568.30-14.95-
Upgrade
EV/Sales Ratio
0.290.320.310.190.170.15
Upgrade
EV/EBITDA Ratio
9.8111.709.4832.8912.337.55
Upgrade
EV/EBIT Ratio
11.4912.8210.15-19.0210.95
Upgrade
EV/FCF Ratio
87.3297.379.38-47.40-
Upgrade
Debt / Equity Ratio
0.030.030.19-0.220.51
Upgrade
Debt / EBITDA Ratio
0.310.311.64-3.495.75
Upgrade
Debt / FCF Ratio
2.772.771.63-13.40-
Upgrade
Asset Turnover
2.172.17--2.462.21
Upgrade
Inventory Turnover
11.1811.18--11.2111.06
Upgrade
Quick Ratio
1.411.412.62-2.171.10
Upgrade
Current Ratio
3.083.084.47-3.741.85
Upgrade
Return on Equity (ROE)
4.52%4.52%--8.64%4.09%
Upgrade
Return on Assets (ROA)
3.42%3.42%--1.38%1.90%
Upgrade
Return on Capital (ROIC)
4.54%4.54%--2.02%2.97%
Upgrade
Return on Capital Employed (ROCE)
7.60%7.60%8.90%-3.30%5.00%
Upgrade
Earnings Yield
4.76%5.38%8.72%-0.06%11.86%6.69%
Upgrade
FCF Yield
1.11%1.26%11.82%-2.44%-71.64%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.